These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32220685)

  • 1. N-benzyl 4,4-disubstituted piperidines as a potent class of influenza H1N1 virus inhibitors showing a novel mechanism of hemagglutinin fusion peptide interaction.
    de Castro S; Ginex T; Vanderlinden E; Laporte M; Stevaert A; Cumella J; Gago F; Camarasa MJ; Luque FJ; Naesens L; Velazquez S
    Eur J Med Chem; 2020 May; 194():112223. PubMed ID: 32220685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermonomer Interactions in Hemagglutinin Subunits HA1 and HA2 Affecting Hemagglutinin Stability and Influenza Virus Infectivity.
    Wang W; DeFeo CJ; Alvarado-Facundo E; Vassell R; Weiss CD
    J Virol; 2015 Oct; 89(20):10602-11. PubMed ID: 26269180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Mechanism Underlying the Action of Influenza A Virus Fusion Inhibitor MBX2546.
    Basu A; Komazin-Meredith G; McCarthy C; Antanasijevic A; Cardinale SC; Mishra RK; Barnard DL; Caffrey M; Rong L; Bowlin TL
    ACS Infect Dis; 2017 May; 3(5):330-335. PubMed ID: 28301927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An N-terminal heptad repeat trimer-based peptide fusion inhibitor exhibits potent anti-H1N1 activity.
    Na H; Luo H; Wang J; Sun L; Gao X; Liang G; Ma Y; Meng Z
    Bioorg Med Chem; 2024 Sep; 111():117865. PubMed ID: 39098126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin.
    Chen X; Si L; Liu D; Proksch P; Zhang L; Zhou D; Lin W
    Eur J Med Chem; 2015 Mar; 93():182-95. PubMed ID: 25681711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superior inhibition of influenza virus hemagglutinin-mediated fusion by indole-substituted spirothiazolidinones.
    Cihan-Üstündağ G; Zopun M; Vanderlinden E; Ozkirimli E; Persoons L; Çapan G; Naesens L
    Bioorg Med Chem; 2020 Jan; 28(1):115130. PubMed ID: 31753804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An induced pocket for the binding of potent fusion inhibitor CL-385319 with H5N1 influenza virus hemagglutinin.
    Li R; Song D; Zhu Z; Xu H; Liu S
    PLoS One; 2012; 7(8):e41956. PubMed ID: 22876294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and structure-activity relationship of novel inhibitors against H5N1 hemagglutinin-mediated membrane fusion.
    Zhu Z; Li R; Xiao G; Chen Z; Yang J; Zhu Q; Liu S
    Eur J Med Chem; 2012 Nov; 57():211-6. PubMed ID: 23059548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An oligothiophene compound neutralized influenza A viruses by interfering with hemagglutinin.
    Shen X; Zhu Z; Ding Y; Wu W; Yang J; Liu S
    Biochim Biophys Acta Biomembr; 2018 Mar; 1860(3):784-791. PubMed ID: 29229526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporin G, an amphibian antimicrobial peptide against influenza and parainfluenza respiratory viruses: Insights into biological activity and mechanism of action.
    De Angelis M; Casciaro B; Genovese A; Brancaccio D; Marcocci ME; Novellino E; Carotenuto A; Palamara AT; Mangoni ML; Nencioni L
    FASEB J; 2021 Feb; 35(2):e21358. PubMed ID: 33538061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of small molecules acting against H1N1 influenza A virus.
    Agamennone M; Pietrantoni A; Superti F
    Virology; 2016 Jan; 488():249-58. PubMed ID: 26655243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors.
    Wang H; Xu R; Shi Y; Si L; Jiao P; Fan Z; Han X; Wu X; Zhou X; Yu F; Zhang Y; Zhang L; Zhang L; Zhou D; Xiao S
    Eur J Med Chem; 2016 Mar; 110():376-88. PubMed ID: 26866456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of amino acids-oleanolic acid conjugates as influenza virus inhibitors.
    Meng L; Su Y; Yang F; Xiao S; Yin Z; Liu J; Zhong J; Zhou D; Yu F
    Bioorg Med Chem; 2019 Dec; 27(23):115147. PubMed ID: 31635892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Silico Design of New Inhibitors Against Hemagglutinin of Influenza.
    Perrier A; Eluard M; Petitjean M; Vanet A
    J Phys Chem B; 2019 Jan; 123(3):582-592. PubMed ID: 30590925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin.
    Vanderlinden E; Göktas F; Cesur Z; Froeyen M; Reed ML; Russell CJ; Cesur N; Naesens L
    J Virol; 2010 May; 84(9):4277-88. PubMed ID: 20181685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of inhibitors of influenza virus membrane fusion: synthesis, structure-activity relationship and in vitro antiviral activity of a novel indole series.
    Brancato V; Peduto A; Wharton S; Martin S; More V; Di Mola A; Massa A; Perfetto B; Donnarumma G; Schiraldi C; Tufano MA; de Rosa M; Filosa R; Hay A
    Antiviral Res; 2013 Aug; 99(2):125-35. PubMed ID: 23707194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of 4-Aminopiperidines as Inhibitors of Influenza A Viral Entry That Are Synergistic with Oseltamivir.
    Gaisina IN; Peet NP; Cheng H; Li P; Du R; Cui Q; Furlong K; Manicassamy B; Caffrey M; Thatcher GRJ; Rong L
    J Med Chem; 2020 Mar; 63(6):3120-3130. PubMed ID: 32069052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New type of anti-influenza agents based on benzo[d][1,3]dithiol core.
    Khomenko TM; Zarubaev VV; Kireeva MV; Volobueva AS; Slita AV; Borisevich SS; Korchagina DV; Komarova NI; Volcho KP; Salakhutdinov NF
    Bioorg Med Chem Lett; 2020 Dec; 30(24):127653. PubMed ID: 33129992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aniline-Based Inhibitors of Influenza H1N1 Virus Acting on Hemagglutinin-Mediated Fusion.
    Leiva R; Barniol-Xicota M; Codony S; Ginex T; Vanderlinden E; Montes M; Caffrey M; Luque FJ; Naesens L; Vázquez S
    J Med Chem; 2018 Jan; 61(1):98-118. PubMed ID: 29220568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent sialic acid inhibitors that target influenza A virus hemagglutinin.
    Chang YJ; Yeh CY; Cheng JC; Huang YQ; Hsu KC; Lin YF; Lu CH
    Sci Rep; 2021 Apr; 11(1):8637. PubMed ID: 33883588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.